NCT01347723

Scrambler Therapy in Treating Pain and Peripheral Neuropathy in Patients Previously Treated With Chemotherapy

Scrambler Therapy for the Treatment of Chemotherapy Induced Peripheral Neuropathy: An Open Access Trial

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 194 (actual)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This pilot clinical trial studies scrambler therapy in treating pain and peripheral neuropathy in patients previously treated with chemotherapy. Scrambler therapy may help relieve pain from peripheral neuropathy caused by chemotherapy

Detailed description

OBJECTIVES: I. To record the types of patients that we treat, along with the reported efficacy and potential toxicity associated with scrambler therapy. II. To get experience with patient reported outcome measurement tools that we use in this trial, including a report of analgesic use. OUTLINE: Patients undergo scrambler therapy for 30 minutes daily for up to 10 consecutive days. Treatment continues in the absence of unacceptable toxicity. After completion of study treatment, patients are followed up for 10 weeks. III. To explore neurologic testing changes in patients receiving scrambler therapy.

Conditions

• Pain
• Peripheral Neuropathy

Interventions

Type	Name	Description
OTHER	scrambler therapy	Undergo scrambler therapy
OTHER	questionnaire administration	Ancillary studies
PROCEDURE	management of therapy complications	Undergo scrambler therapy

Timeline

• Start date: 2011-03-01
• Primary completion: 2015-12-01
• Completion: 2015-12-01
• First posted: 2011-05-04
• Last updated: 2020-05-14

Locations

1 site across 1 country: United States